NewsSource: EClinCloud Official Website Archive

Good News! EClinCloud Wins First Prize at the Inaugural AI-Empowered Industry Competition

1 min readEClinCloud Editorial Team
Archived article cover: Good news! EClinCloud wins First Prize at the Inaugural AI-Empowered Industry Competition

At the recently concluded inaugural "AI Ningbo" AI-Empowered Industry Competition, EClinCloud stood out from 1190 projects across more than 20 countries and regions worldwide, winning the competition's highest award, First Prize (with no Grand Prize awarded), and receiving associated funding support.

This competition, which tested core AI technical capabilities, fully validated EClinCloud's technical foundation and implementation capabilities in "AI + clinical trials" and demonstrated its strong product capabilities and potential for industry leadership.

一临云AI宁波首届产业大赛一等奖证书  

 

 

 

Using AI to Empower the Full Clinical Drug Development Process

一临云临床研发AI应用介绍  

 

Across the full lifecycle of new drug R&D, EClinCloud has built an intelligent, integrated cloud platform based on core products such as EDC, eCOA, CTMS, eTMF, RTSM, and IRC, breaking down data silos and achieving end-to-end workflow collaboration.

Meanwhile, EClinCloud relies on its self-developed AI technology platform and in-house large models to deeply integrate AI into key stages such as data analysis and risk prediction, building intelligent decision-support and drug R&D prediction models and comprehensively improving clinical R&D efficiency and decision-making quality.

 

AI宁波首届人工智能赋能产业大赛决赛现场  

EClinCloud Founder & CEO Dr. Qin Long said:

"This award not only reflects the application value and prospects of AI technology in clinical research, but also validates EClinCloud's overall strength in model capabilities and product deployment. We will continue to strengthen our technical foundation and focus on real-world pain points to advance intelligent transformation across the entire clinical research workflow."

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.